Myosana Therapeutics

About:

Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.

Website: https://www.myosanatherapeutics.com/

Top Investors: Muscular Dystrophy Association, John Ballantyne, Parent Project Muscular Dystrophy, CureDuchenne Ventures

Description:

Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery. Myosana Therapeutics has developed a non-viral gene delivery platform technology that specifically targets muscle cells to produce the missing protein caused by a mutation of a gene.